DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 203 filers reported holding DIPLOMAT PHARMACY INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $949,000 | -8.0% | 47,097 | -8.3% | 0.20% | -30.0% |
| Q4 2017 | $1,031,000 | -7.3% | 51,358 | -4.3% | 0.29% | -9.5% |
| Q3 2017 | $1,112,000 | +40.1% | 53,677 | 0.0% | 0.32% | +61.7% |
| Q2 2017 | $794,000 | +128.8% | 53,677 | +95.2% | 0.20% | +127.9% |
| Q4 2016 | $347,000 | -54.9% | 27,503 | 0.0% | 0.09% | -55.2% |
| Q3 2016 | $770,000 | -20.0% | 27,503 | 0.0% | 0.19% | -27.3% |
| Q2 2016 | $963,000 | +27.7% | 27,503 | 0.0% | 0.26% | +30.7% |
| Q1 2016 | $754,000 | -8.9% | 27,503 | +13.6% | 0.20% | -8.6% |
| Q4 2015 | $828,000 | – | 24,205 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |